Interleukin-6 Receptor Antagonist [EPC]

87990 reported adverse events

Drugs of this class: SARILUMAB TOCILIZUMAB

These side effects are most commonly reported by patients taking drugs of the Interleukin-6 Receptor Antagonist [EPC] class:

# Side effect Count
0 DRUG INEFFECTIVE 30244
1 RHEUMATOID ARTHRITIS 18003
2 PAIN 15285
3 ARTHRALGIA 12674
4 OFF LABEL USE 12365
5 JOINT SWELLING 11641
6 FATIGUE 10590
7 DRUG INTOLERANCE 9694
8 RASH 9445
9 CONTRAINDICATED PRODUCT ADMINISTERED 8927
See all common reactions for Interleukin-6 Receptor Antagonist [EPC]

Drugs of the Interleukin-6 Receptor Antagonist [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HUMAN ANTICHIMERIC ANTIBODY POSITIVE 273 0.9286
1 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 3050 0.9050
2 SWOLLEN JOINT COUNT INCREASED 666 0.8880
3 DISABILITY ASSESSMENT SCALE SCORE INCREASED 206 0.8692
4 RHEUMATOID FACTOR POSITIVE 2494 0.8121
5 RED BLOOD CELL SEDIMENTATION RATE 188 0.8069
6 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 111 0.7986
7 PEMPHIGUS 5531 0.7853
8 RHEUMATOID FACTOR NEGATIVE 131 0.7844
9 RHEUMATIC FEVER 805 0.7495
See all enriched reactions for Interleukin-6 Receptor Antagonist [EPC]